Varex Imaging’s (VREX) Neutral Rating Reiterated at Sidoti

Sidoti reiterated their neutral rating on shares of Varex Imaging (NASDAQ:VREX) in a research report released on Monday morning,Benzinga reports. Sidoti currently has a $19.00 price objective on the stock.

A number of other equities research analysts have also recently commented on VREX. Wall Street Zen raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Zacks Research cut shares of Varex Imaging from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 27th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a report on Wednesday, June 24th. Five investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Reduce” and a consensus target price of $16.88.

Varex Imaging Stock Down 0.7%

Shares of VREX opened at $18.45 on Monday. Varex Imaging has a 52 week low of $9.09 and a 52 week high of $18.63. The company has a quick ratio of 1.43, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $776.75 million, a price-to-earnings ratio of 35.48 and a beta of 0.89. The stock’s 50-day moving average price is $11.27 and its 200-day moving average price is $11.61.

Varex Imaging (NASDAQ:VREX) last posted its earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.21 by $0.10. The firm had revenue of $210.50 million for the quarter, compared to analyst estimates of $215.50 million. Varex Imaging had a return on equity of 9.29% and a net margin of 2.55%. On average, sell-side analysts predict that Varex Imaging will post 0.93 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Varex Imaging in the fourth quarter valued at approximately $1,247,000. LSV Asset Management lifted its position in Varex Imaging by 210.7% during the fourth quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock worth $14,496,000 after buying an additional 843,805 shares in the last quarter. Rice Hall James & Associates LLC lifted its position in Varex Imaging by 19.1% during the fourth quarter. Rice Hall James & Associates LLC now owns 1,082,964 shares of the company’s stock worth $12,617,000 after buying an additional 173,703 shares in the last quarter. Sei Investments Co. boosted its stake in Varex Imaging by 72.5% during the first quarter. Sei Investments Co. now owns 411,655 shares of the company’s stock worth $4,368,000 after buying an additional 173,041 shares during the last quarter. Finally, Legato Capital Management LLC boosted its stake in Varex Imaging by 889.9% during the fourth quarter. Legato Capital Management LLC now owns 99,810 shares of the company’s stock worth $1,163,000 after buying an additional 89,727 shares during the last quarter.

Key Varex Imaging News

Here are the key news stories impacting Varex Imaging this week:

• Positive Sentiment: Varex reported quarterly adjusted earnings of $0.31 per share, exceeding the analyst consensus of $0.21. The strong earnings performance helped drive the stock to a new 52-week high. Varex Imaging Sets New 1-Year High After Strong Earnings
• Positive Sentiment: Teledyne’s proposed acquisition provides Varex shareholders with a specified $18.90-per-share cash consideration, while commentary described the transaction as strengthening the investment case for Teledyne. Teledyne to Acquire Varex in $1.1 Billion Deal
• Neutral Sentiment: Sidoti reiterated a Neutral rating on VREX, suggesting the shares are fairly valued around the announced transaction price and that substantial additional upside may be difficult without a higher offer. Sidoti Reiterates Neutral Rating for Varex Imaging
• Negative Sentiment: Law firm Kahn Swick & Foti said it is investigating whether the proposed sale price and deal process adequately protect Varex shareholders. Such reviews can create uncertainty around deal approval, although no wrongdoing has been established. Varex Imaging Investor Alert

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.